Skip to main content

Genprex, Inc.

GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595248

No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.

Holders of 5% or more of GNPX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Genprex, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Genprex, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

14 Schedule 13D and 13G filings on Genprex, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GNPX
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 11, 20265:52 PM ETAyrton Capital LLCand 2 others13G/A2.69%249.8K shares−7.03 ppfrom 9.72%Below 5%Mar 31, 2026SEC
Feb 11, 202610:05 AM ETAyrton Capital LLCand 2 others13G9.72%249.8K sharesNewDec 31, 2025SEC
Nov 3, 20255:14 PM ETIntracoastal Capital, LLCand 2 others13G4.99%84.8K sharesNewBelow 5%Oct 28, 2025SEC
Jan 15, 20256:06 AM ETForsakringsaktiebolaget Avanza Pension13G0.02%5.97K shares–Below 5%Dec 31, 2024SEC
Oct 24, 2024Otsuka Masaya13G/AOld format–––SEC
Oct 22, 2024Otsuka Masaya13GOld format–New–SEC
Oct 3, 2024Forsakringsaktiebolaget Avanza Pension13GOld format–New–SEC
Feb 14, 2024CVI Investments, Inc.13G/AOld format–––SEC
Jul 24, 2023CVI Investments, Inc.13GOld format–––SEC
Feb 19, 2021Altium Capital Management LP13G/AOld format–––SEC
Feb 16, 2021Altium Capital Management LP13G/AOld format–––SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC
Feb 9, 2021Hudson Bay Capital Management LP13G/AOld format–––SEC
Jan 4, 2021Sabby Management, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Genprex, Inc. shares.

No Form 144 notices for Genprex, Inc. are on file.